1afbc3ed-f46e-4966-af46-fb79bb8567ec beie director@blueeyesintelligence.org 10.35940/ijrte.C7288.0911322 Breast cancer. (2021, March 26). WHO | World Health Organization. Retrieved April 18, 2022, from https://www.who.int/news-room/fact-sheets/detail/breast-cancer10.1200/JCO.2006.09.1066Chen, S., & Parmigiani, G. (n.d.). Meta-analysis of BRCA1 and BRCA2 penetrance. journal of Clinical Oncology 2007, 25(11), 1329-1333. [CrossRef]Kuchenbaecker, K., JL, H., & DR, B. (n.d.). Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers. JAMA 2017, 317(23), 2402-2416. [CrossRef]10.1158/1055-9965.EPI-15-0535DeSantis, C., Bray, F., Ferlay, J., Lortet-Tieulent, J., Anderson, B., & Jemal, A. (n.d.). International Variation in Female Breast Cancer Incidence and Mortality Rates. Cancer Epidemiol Biomarkers Prev. 2015, 24(10), 1495-506. [CrossRef]Breast Cancer Statistics | Facts & Figures | NBCC. (n.d.). National Breast Cancer Coalition. Retrieved April 19, 2022, from https://www.stopbreastcancer.org/information-center/facts-figures/10.4103/bbrj.bbrj_131_21Parekh, D. H., & Dahiya, V. (2021, October). Predicting breast cancer using machine learning classifiers and enhancing the output by combining the predictions to generate optimal F1-score. Biomedical and Biotechnology Research Journal (BBRJ), 5(3), 331 - 334. 10.4103/bbrj.bbrj_131_21. [CrossRef]